Cited by

• Pandemic-response adenoviral vector and RNA vaccine manufacturing.

  Kis Z, Tak K, Ibrahim D, Papathanasiou MM, Chachuat B, Shah N, Kontoravdi C. Kis Z, et al. NPJ Vaccines. 2022 Mar 2;7(1):29. doi: 10.1038/s41541-022-00447-3. NPJ Vaccines. 2022. PMID: 35236838 Free PMC article.
• A comparison of seasonal influenza and novel Covid-19 vaccine intentions: A cross-sectional survey of vaccine hesitant adults in England during the 2020 pandemic.

  Antonopoulou V, Goffe L, Meyer CJ, Grimani A, Graham F, Lecouturier J, Tang MY, Chadwick P, Sniehotta FF. Antonopoulou V, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2085461. doi: 10.1080/21645515.2022.2085461. Epub 2022 Jul 11. Hum Vaccin Immunother. 2022. PMID: 35816683 Free PMC article.
• International Efforts and Next Steps to Advance COVID-19 Vaccines Research and Production in Low- and Middle-Income Countries.

  Du L, Wang M, Raposo VL. Du L, et al. Vaccines (Basel). 2021 Dec 29;10(1):42. doi: 10.3390/vaccines10010042. Vaccines (Basel). 2021. PMID: 35062703 Free PMC article.
• Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19.

  Frumkin LR, Lucas M, Scribner CL, Ortega-Heinly N, Rogers J, Yin G, Hallam TJ, Yam A, Bedard K, Begley R, Cohen CA, Badger CV, Abbasi SA, Dye JM, McMillan B, Wallach M, Bricker TL, Joshi A, Boon ACM, Pokhrel S, Kraemer BR, Lee L, Kargotich S, Agochiya M, John TS, Mochly-Rosen D. Frumkin LR, et al. Front Immunol. 2022 Jun 1;13:899617. doi: 10.3389/fimmu.2022.899617. eCollection 2022. Front Immunol. 2022. PMID: 35720389 Free PMC article. Clinical Trial.
• A Perspective on the Role of Point-of-Care "Immuno-Triaging" to Optimize COVID-19 Vaccination Distribution in a Time of Scarcity.

  Zhang Y, Rogers A, Nadeau K, Gu J, Yang S. Zhang Y, et al. Front Public Health. 2021 Aug 3;9:638316. doi: 10.3389/fpubh.2021.638316. eCollection 2021. Front Public Health. 2021. PMID: 34414149 Free PMC article.